A citation-based method for searching scientific literature

Tyler Shugg, Amy L Pasternak, Bianca London, Jasmine A Luzum. NPJ Genom Med 2020
Times Cited: 4







List of co-cited articles
14 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Adoption of pharmacogenomic testing by US physicians: results of a nationwide survey.
E J Stanek, C L Sanders, K A Johansen Taber, M Khalid, A Patel, R R Verbrugge, B C Agatep, R E Aubert, R S Epstein, F W Frueh. Clin Pharmacol Ther 2012
271
75


Pharmacogenomics in the clinic.
Mary V Relling, William E Evans. Nature 2015
371
50

Comparison of delivery strategies for pharmacogenetic testing services.
Susanne B Haga, Jivan Moaddeb. Pharmacogenet Genomics 2014
31
50

Standardization can accelerate the adoption of pharmacogenomics: current status and the path forward.
Kelly E Caudle, Nicholas J Keeling, Teri E Klein, Michelle Whirl-Carrillo, Victoria M Pratt, James M Hoffman. Pharmacogenomics 2018
32
50


Design and Early Implementation Successes and Challenges of a Pharmacogenetics Consult Clinic.
Meghan J Arwood, Eric A Dietrich, Benjamin Q Duong, D Max Smith, Kelsey Cook, Amanda Elchynski, Eric I Rosenberg, Katherine N Huber, Ying L Nagoshi, Ashleigh Wright,[...]. J Clin Med 2020
13
50

A Genotype-Guided Strategy for Oral P2Y12 Inhibitors in Primary PCI.
Daniel M F Claassens, Gerrit J A Vos, Thomas O Bergmeijer, Renicus S Hermanides, Arnoud W J van 't Hof, Pim van der Harst, Emanuele Barbato, Carmine Morisco, Richard M Tjon Joe Gin, Folkert W Asselbergs,[...]. N Engl J Med 2019
182
50

Physician-Reported Benefits and Barriers to Clinical Implementation of Genomic Medicine: A Multi-Site IGNITE-Network Survey.
Aniwaa Owusu Obeng, Kezhen Fei, Kenneth D Levy, Amanda R Elsey, Toni I Pollin, Andrea H Ramirez, Kristin W Weitzel, Carol R Horowitz. J Pers Med 2018
58
50

Prevalence and types of inconsistencies in clinical pharmacogenetic recommendations among major U.S. sources.
Tyler Shugg, Amy L Pasternak, Bianca London, Jasmine A Luzum. NPJ Genom Med 2020
2
100

The Pharmacogenomics Research Network Translational Pharmacogenetics Program: Outcomes and Metrics of Pharmacogenetic Implementations Across Diverse Healthcare Systems.
J A Luzum, R E Pakyz, A R Elsey, C E Haidar, J F Peterson, M Whirl-Carrillo, S K Handelman, K Palmer, J M Pulley, M Beller,[...]. Clin Pharmacol Ther 2017
81
50

Facilitators and Barriers to the Adoption of Pharmacogenetic Testing in an Inner-City Population.
Yee Ming Lee, Beenish S Manzoor, Larisa H Cavallari, Edith A Nutescu. Pharmacotherapy 2018
12
50

Effect of Genotype-Guided Oral P2Y12 Inhibitor Selection vs Conventional Clopidogrel Therapy on Ischemic Outcomes After Percutaneous Coronary Intervention: The TAILOR-PCI Randomized Clinical Trial.
Naveen L Pereira, Michael E Farkouh, Derek So, Ryan Lennon, Nancy Geller, Verghese Mathew, Malcolm Bell, Jang-Ho Bae, Myung Ho Jeong, Ivan Chavez,[...]. JAMA 2020
84
50

Comparison of the Guidelines of the Clinical Pharmacogenetics Implementation Consortium and the Dutch Pharmacogenetics Working Group.
P C D Bank, K E Caudle, J J Swen, R S Gammal, M Whirl-Carrillo, T E Klein, M V Relling, H-J Guchelaar. Clin Pharmacol Ther 2018
106
50




Genetic variation and pharmacogenomics: concepts, facts, and challenges.
Margret R Hoehe, Thomas Kroslak. Dialogues Clin Neurosci 2004
5
25

Realities and expectations of pharmacogenomics and personalized medicine: impact of translating genetic knowledge into clinical practice.
Alessio Squassina, Mirko Manchia, Vangelis G Manolopoulos, Mehmet Artac, Christina Lappa-Manakou, Sophia Karkabouna, Konstantinos Mitropoulos, Maria Del Zompo, George P Patrinos. Pharmacogenomics 2010
82
25

The general public's understanding and perception of direct-to-consumer genetic test results.
J W Leighton, K Valverde, B A Bernhardt. Public Health Genomics 2012
84
25

Current ethical and legal issues in health-related direct-to-consumer genetic testing.
Emilia Niemiec, Louiza Kalokairinou, Heidi Carmen Howard. Per Med 2017
12
25

Exploring public genomics data for population pharmacogenomics.
Kleanthi Lakiotaki, Alexandros Kanterakis, Evgenia Kartsaki, Theodora Katsila, George P Patrinos, George Potamias. PLoS One 2017
23
25


Legislation of direct-to-consumer genetic testing in Europe: a fragmented regulatory landscape.
L Kalokairinou, H C Howard, S Slokenberga, E Fisher, M Flatscher-Thöni, M Hartlev, R van Hellemondt, J Juškevičius, J Kapelenska-Pregowska, P Kováč,[...]. J Community Genet 2018
32
25

The Human Genome Project: lessons from large-scale biology.
Francis S Collins, Michael Morgan, Aristides Patrinos. Science 2003
394
25

Pharmacogenomics guidelines: Current status and future development.
Chengxian Guo, Xiaoxue Xie, Jingao Li, Lihua Huang, Shaojun Chen, Xi Li, Xin Yi, Qin Wu, Guoping Yang, Honghao Zhou,[...]. Clin Exp Pharmacol Physiol 2019
8
25

Direct-to-Consumer Testing 2.0: Emerging Models of Direct-to-Consumer Genetic Testing.
Megan A Allyse, David H Robinson, Matthew J Ferber, Richard R Sharp. Mayo Clin Proc 2018
54
25

Prescription medication changes following direct-to-consumer personal genomic testing: findings from the Impact of Personal Genomics (PGen) Study.
Deanna Alexis Carere, Tyler J VanderWeele, Jason L Vassy, Cathelijne H van der Wouden, J Scott Roberts, Peter Kraft, Robert C Green. Genet Med 2017
19
25

Publications from industry. Personal and corporate incentives.
Anthony J Kinney, Enno Krebbers, Steven J Vollmer. Plant Physiol 2004
2
50

Pharmacogenomics-Based Point-of-Care Clinical Decision Support Significantly Alters Drug Prescribing.
P H O'Donnell, N Wadhwa, K Danahey, B A Borden, S M Lee, J P Hall, C Klammer, S Hussain, M Siegler, M J Sorrentino,[...]. Clin Pharmacol Ther 2017
48
25

Updating the landscape of direct-to-consumer pharmacogenomic testing.
Kelly K Filipski, John D Murphy, Kathy J Helzlsouer. Pharmgenomics Pers Med 2017
10
25

Direct-to-consumer genetic testing: a systematic review of european guidelines, recommendations, and position statements.
Muhammad Rafiq, Carolina Ianuale, Walter Ricciardi, Stefania Boccia. Genet Test Mol Biomarkers 2015
22
25


Pharmacogenetic testing through the direct-to-consumer genetic testing company 23andMe.
Mengfei Lu, Cathryn M Lewis, Matthew Traylor. BMC Med Genomics 2017
16
25

Ethical issues in consumer genome sequencing: Use of consumers' samples and data.
Emilia Niemiec, Heidi Carmen Howard. Appl Transl Genom 2016
25
25

Genetic variation in human drug-related genes.
Charlotta Pauline Irmgard Schärfe, Roman Tremmel, Matthias Schwab, Oliver Kohlbacher, Debora Susan Marks. Genome Med 2017
51
25



SUSHI: an exquisite recipe for fully documented, reproducible and reusable NGS data analysis.
Masaomi Hatakeyama, Lennart Opitz, Giancarlo Russo, Weihong Qi, Ralph Schlapbach, Hubert Rehrauer. BMC Bioinformatics 2016
37
25

The rise and fall and rise again of 23andMe.
Erika Check Hayden. Nature 2017
17
25


The current landscape for direct-to-consumer genetic testing: legal, ethical, and policy issues.
Stuart Hogarth, Gail Javitt, David Melzer. Annu Rev Genomics Hum Genet 2008
154
25


Whole genome sequencing in pharmacogenomics.
Theodora Katsila, George P Patrinos. Front Pharmacol 2015
25
25

Integrating pharmacogenetic testing into primary care.
Susanne B Haga. Expert Rev Precis Med Drug Dev 2017
3
33

Clinical utility of microarrays: current status, existing challenges and future outlook.
Xinmin Li, Richard J Quigg, Jian Zhou, Weikuan Gu, P Nagesh Rao, Elaine F Reed. Curr Genomics 2008
37
25

Comprehension and Data-Sharing Behavior of Direct-To-Consumer Genetic Test Customers.
Scott P McGrath, Jason Coleman, Lotfollah Najjar, Ann Fruhling, Dhundy R Bastola. Public Health Genomics 2016
18
25



ACG Clinical Guideline: Management of Crohn's Disease in Adults.
Gary R Lichtenstein, Edward V Loftus, Kim L Isaacs, Miguel D Regueiro, Lauren B Gerson, Bruce E Sands. Am J Gastroenterol 2018
402
25


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.